Method of monitoring membrane separation processes

Methods and systems for monitoring and controlling membrane separation systems are provided. The present invention uses measurable amounts of one or more inert fluorescent tracers added to a feed stream to evaluate and/or control the unit operation of processing such feed stream during membrane separation. The methods and systems of the present invention can be used in a variety of different industrial applications including raw water processing and waste water processing.

Skip to: Description  ·  Claims  · Patent History  ·  Patent History
Description
CROSS-REFERENCE TO RELATED PATENT APPLICATIONS

[0001] This patent application is a continuation-in-part of U.S. patent application Ser. No. 10/109,256, filed Mar. 28, 2002, now pending.

FIELD OF THE INVENTION

[0002] This invention relates generally to membrane separation and, more particularly, to methods for monitoring and/or controlling membrane separation processes.

BACKGROUND OF THE INVENTION

[0003] Membrane separation, which uses a selective membrane, is a fairly recent addition to the industrial separation technology for processing of liquid streams, such as water purification. In membrane separation, constituents of the influent typically pass through the membrane as a result of a driving force(s) in the feed stream, to form the permeate stream (on the other side of the membrane), thus leaving behind some portion of the original constituents in a stream known as the concentrate.

[0004] Membrane separations commonly used for water purification or other liquid processing include microfiltration (MF), ultrafiltration (UF), nanofiltration (NF), reverse osmosis (RO), electrodialysis, electrodeionization, pervaporation, membrane extraction, membrane distillation, membrane stripping, membrane aeration, and other processes.

[0005] Pressure-driven membrane filtration uses pressure as the driving force. Pressure-driven membrane filtration is also known as membrane filtration. Pressure-driven membrane filtration includes microfiltration, ultrafiltration, nanofiltration and reverse osmosis. In contrast to pressure driven membrane filtration an electrical driving force is used in electrodialysis and electrodeionization.

[0006] Historically, membrane separation processes or systems were not considered cost effective for water treatment due to the adverse impacts that membrane scaling, membrane fouling, membrane degradation and the like had on the efficiency of removing solutes from aqueous water streams. However, advancements in technology have now made membrane separation a more commercially viable technology for treating aqueous feed streams suitable for use in industrial processes.

[0007] Furthermore, membrane separation processes have also been made more practical for industrial use, particularly for raw and wastewater purification. This has been achieved through the use of improved diagnostic tools or techniques for evaluating membrane separation performance. The performance of membrane separation, such as efficiency (e.g. flux or membrane permeability) and effectiveness (e.g. rejection or selectivity), are typically affected by various parameters concerning the operating conditions of the process. Therefore, it is desirable to monitor these and other types of process parameters specific to membrane separation to assess the performance of the process and/or the operating conditions. In this regard, a variety of different diagnostic techniques for monitoring membrane separation processes have been routinely used and are now understood and accepted as essential to its practicality and viability for industrial use.

[0008] However, monitoring is typically conducted on an intermittent basis, for example, once a work shift or at times less frequently. Known employed monitoring techniques can also be labor and time intensive. Thus, adjustments made to membrane separation processes in order to enhance performance based on typical monitoring may not be made in an expeditious manner. In addition, the presently available monitoring techniques often do not provide optimal sensitivity and selectivity with respect to monitoring a variety of process parameters, such as conductivity measurements and flow measurements, that are generally relied on as indicators to evaluate and/or control membrane separation processes.

[0009] Accordingly, a need exists to monitor and/or control membrane separation processes which can treat feed streams, such as aqueous feed streams, suitable for use in industrial processes where conventional monitoring techniques are generally complex and/or may lack the sensitivity and selectivity necessary to adequately monitor one or more process parameters specific to membrane separation processes which are important to the evaluation of the performance of membrane separation.

SUMMARY OF THE INVENTION

[0010] The first aspect of the instant claimed invention is a method of monitoring a membrane separation process including a membrane capable of separating a feed stream into at least a first stream, known as the concentrate, and a second stream, known as the permeate, comprising the steps of:

[0011] (a) selecting an inert fluorescent tracer wherein the selection is made such that it is known in advance whether said inert fluorescent tracer is

[0012] (i) capable of traveling through the membrane into the permeate stream, or

[0013] (ii) not capable of passing through the membrane into the permeate stream;

[0014] (b) introducing the inert fluorescent tracer into the feed stream;

[0015] (c) providing one or more fluorometers to detect the fluorescent signal of the inert fluorescent tracer in at least one of the feed stream, the concentrate and optionally the permeate;

[0016] (d) using said one or more fluorometers to detect the fluorescent signal of the inert fluorescent tracer in at least one of the feed stream, the concentrate and optionally the permeate; and

[0017] (e) using the detected fluorescent signal of the inert fluorescent tracer to determine the amount of inert fluorescent tracer in at least one of the feed stream, the concentrate and optionally the permeate.

[0018] The second aspect of the instant claimed invention is a method of monitoring a membrane separation system including a membrane capable of removing solutes from a feed stream, wherein said membrane is suitable for use in an industrial water system, comprising the steps of:

[0019] (a) selecting an inert fluorescent tracer wherein the selection is made such that it is known in advance whether said inert fluorescent tracer is

[0020] (i) capable of traveling through the membrane into the permeate stream, or

[0021] (ii) not capable of passing through the membrane into the permeate stream;

[0022] (b) introducing the inert fluorescent tracer into the feed stream;

[0023] (c) contacting the membrane with the feed stream;

[0024] (d) using the membrane to remove solutes from the feed stream by separating the feed stream into a permeate stream and a concentrate stream;

[0025] (e) providing one or more fluorometers to detect the fluorescent signal of the inert fluorescent tracer in at least one of the feed stream, the concentrate and optionally the permeate;

[0026] (f) using said one or more fluorometers to detect the fluorescent signal of the inert fluorescent tracer in at least one of the feed stream, the concentrate and optionally the permeate; and

[0027] (g) using the detected fluorescent signal of the inert fluorescent tracer to determine the amount of inert fluorescent tracer in at least one of the feed stream, the concentrate and optionally the permeate.

[0028] The third aspect of the instant claimed invention is a membrane separation system capable of purifying an aqueous feed stream suitable for use in an industrial process comprising:

[0029] (a) a semi-permeable membrane capable of separating the aqueous feed stream containing an inert tracer into a permeate stream and a concentrate stream to remove one or more solutes from the aqueous feed stream; wherein the inert fluorescent tracer is selected such that it is known in advance whether said inert fluorescent tracer is

[0030] (i) capable of traveling through the membrane into the permeate stream, or

[0031] (ii) not capable of passing through the membrane into the permeate stream;

[0032] (b) one or more fluorometers, capable of fluorometrically measuring an amount of the inert tracer ranging from about 5 ppt to about 1000 ppm in at least one of the aqueous feed stream, the concentrate and optionally the permeate wherein the detection device is capable of producing a signal indicative of the amount of inert tracer that is detected; and

[0033] (c) a controller capable of processing the signal to monitor and/or control the purification of the aqueous feed stream.

[0034] The fourth aspect of the instant claimed invention is a method of monitoring and controlling a membrane separation process including a membrane capable of removing solutes from a feed stream for use in an industrial process comprising the steps of:

[0035] (a) adding an inert tracer to the feed stream; wherein the inert fluorescent tracer is selected such that it is known in advance whether said inert fluorescent tracer is

[0036] (i) capable of traveling through the membrane into the permeate stream, or

[0037] (ii) not capable of passing through the membrane into the permeate stream;

[0038] (b) contacting the membrane with the feed stream;

[0039] (c) using the membrane to remove solutes from the feed stream by separating the feed stream into a permeate stream and a concentrate stream;

[0040] (d) providing one or more fluorometers to detect the fluorescent signal of the inert fluorescent tracer in at least one of the feed stream, the concentrate and optionally the permeate;

[0041] (e) using said one or more fluorometers to detect the fluorescent signal of the inert fluorescent tracer, ranging from about 5 ppt to about 1000 ppm, in at least one of the feed stream, the concentrate and optionally the permeate; and

[0042] (f) using the detected fluorescent signal of the inert fluorescent tracer to determine the amount of inert fluorescent tracer in at least one of the feed stream, the concentrate and optionally the permeate;

[0043] (g) evaluating one or more process parameters specific to the membrane separation process based on the detectable amount of the inert tracer.

DETAILED DESCRIPTION OF THE PRESENTLY PREFERRED EMBODIMENTS

[0044] Throughout this patent application, the following terms have the indicated meanings:

[0045] “capable” means “having the ability or qualities necessary for a certain task”.

[0046] “Nalco” refers to Nalco Company, 1601 W. Diehl Road, Naperville, Ill. 60563, (630) 305-1000.

[0047] “pore” A pore is a pathway, which functions as the means by which “something” is intended to pass through a membrane surface. The “something” may be a solute, a particle, a molecule or anything of such dimension that it is capable of fitting through the pore. A “pore” is different than a “hole” in the membrane because “holes” or “defects” in the membrane are not intended to be present in the membrane. A “pore” may be an opening of a defined size and shape, for example a cylindrical pore with a 0.2 micron diameter. Alternatively, a “pore” may be a torturous path consisting of a series of openings of undefined shape which allow particles of only a certain overall size to pass. The term “pore” is generally not in common usage with reverse osmosis membranes because with reverse osmosis membranes the “pores” may only be as small as the interstitial voids between the polymer nodules in a polymer membrane.

[0048] “semi-permeable membrane” is a membrane that allows solutes, up to a certain molecular weight and with the appropriate charge, to pass through. Typically reverse osmosis membranes are semi-permeable membranes.

[0049] The first aspect of the instant claimed invention is a method of monitoring a membrane separation process including a membrane capable of separating a feed stream into at least a first stream, known as the concentrate, and a second stream, known as the permeate, comprising the steps of:

[0050] (a) selecting an inert fluorescent tracer wherein the selection is made such that it is known in advance whether said inert fluorescent tracer is

[0051] (i) capable of traveling through the membrane into the permeate stream, or

[0052] (ii) not capable of passing through the membrane into the permeate stream;

[0053] (b) introducing the inert fluorescent tracer into the feed stream;

[0054] (c) providing one or more fluorometers to detect the fluorescent signal of the inert fluorescent tracer in at least one of the feed stream, the concentrate and optionally the permeate;

[0055] (d) using said one or more fluorometers to detect the fluorescent signal of the inert fluorescent tracer in at least one of the feed stream, the concentrate and optionally the permeate; and

[0056] (e) using the detected fluorescent signal of the inert fluorescent tracer to determine the amount of inert fluorescent tracer in at least one of the feed stream, the concentrate and optionally the permeate.

[0057] The methods and systems of the present invention can include a variety of different and suitable components, process steps, operating conditions and the like, for monitoring and/or controlling membrane separation processes or systems.

[0058] The membrane separation processes of the instant invention are capable of treating or purifying feed streams by dividing the feed stream into separate streams. In an embodiment, the feed stream is separated into at least a first and second stream, with the first stream being the concentrate stream and the second stream being the permeate stream. The feed stream can contain various solutes, such as dissolved organics, dissolved inorganics, dissolved solids, suspended solids, the like or combinations thereof. Upon contact with the membrane, the feed stream is separated into the permeate, which is that part of the feed stream that has passed through the pores of the membrane and the concentrate, which is that part of the feed stream that did not pass through the pores of the membrane. Typically the permeate stream contains a substantially lower concentration of dissolved and/or suspended solutes as compared to the aqueous feed stream. In contrast, the concentrate stream has a higher concentration of dissolved and/or suspended solutes as compared to the aqueous stream. In this regard, the permeate represents a purified stream, such as a purified aqueous stream.

[0059] It should be appreciated that the present invention can be used with respect to a number of different types of membrane separation processes including, for example, cross flow processes, dead-end flow processes, reverse osmosis, ultrafiltration, microfiltration, nanofiltration, electrodialysis, electrodeionization, pervaporation, membrane extraction, membrane distillation, membrane stripping, membrane aeration and the like or combinations thereof.

[0060] The membrane separation process of the present invention includes cross flow and dead-end flow processes. During cross flow processes, the feed stream can be treated in a flow direction that is substantially parallel to the membrane of the separation system. With respect to dead-end flow separation processes, the feed stream can be treated in a flow direction that is substantially perpendicular to the membrane of the separation system.

[0061] Reverse osmosis, ultrafiltration, microfiltration and nanofiltration are the preferred membrane separation processes.

[0062] In reverse osmosis, the feed stream is typically processed under cross flow conditions. In this regard, the feed stream flows substantially parallel to the membrane surface such that only a portion of the feed stream diffuses through the membrane as permeate. The cross flow rate is routinely high in order to provide a scouring action that lessens membrane surface fouling. This can also decrease concentration polarization effects (e.g., concentration of solutes in the reduced-turbulence boundary layer at the membrane surface, which can increase the osmotic pressure at the membrane and thus can reduce permeate flow). The concentration polarization effects can inhibit the feed stream water from passing through the membrane as permeate, thus decreasing the recovery ratio, e.g., the ratio of permeate to applied feed stream. A recycle loop(s) may be employed to maintain a high flow rate across the membrane surface.

[0063] Reverse osmosis processes can employ a variety of different types of membranes. Such commercial membrane element types include, without limitation, hollow fiber membrane elements, tubular membrane elements, spiral-wound membrane elements, plate and frame membrane elements, and the like, some of which are described in more detail in “The Nalco Water Handbook,” Second Edition, Frank N. Kemmer ed., McGraw-Hill Book Company, New York, N.Y., 1988, particularly Chapter 15 entitled “Membrane Separation”.

[0064] It should be appreciated that a single membrane element may be used in a given membrane filtration system, but a number of membrane elements can also be used depending on the industrial application.

[0065] A typical reverse osmosis system is described as an example of membrane filtration and more generally membrane separation. Reverse osmosis uses mainly spiral wound elements or modules, which are constructed by winding layers of semi-porous membranes with feed spacers and permeate water carriers around a central perforated permeate collection tube. Typically, the modules are sealed with tape and/or fiberglass over-wrap. The resulting construction has one channel which can receive an inlet flow. The inlet stream flows longitudinally along the membrane module and exits the other end as a concentrate stream. Within the module, water passes through the semi-porous membrane and is trapped in a permeate channel which flows to a central collection tube. From this tube it flows out of a designated channel and is collected.

[0066] In practice, membrane modules are stacked together, end to end, with inter-connectors joining the permeate tubes of the first module to the permeate tube of the second module, and so on. These membrane module stacks are housed in pressure vessels. Within the pressure vessel feed water passes into the first module in the stack, which removes a portion of the water as permeate water. The concentrate stream from the first membrane becomes the feed stream of the second membrane and so on down the stack. The permeate streams from all of the membranes in the stack are collected in the joined permeate tubes. Only the feed stream entering the first module, the combined permeate stream and the final concentrate stream from the last module in the stack are commonly monitored.

[0067] Within most reverse osmosis systems, pressure vessels are arranged in either “stages” or “passes.” In a staged membrane system, the combined concentrate streams from a bank of pressure vessels are directed to a second bank of pressure vessels where they become the feed stream for the second stage. Commonly systems have 2 to 3 stages with successively fewer pressure vessels in each stage. For example, a system may contain 4 pressure vessels in a first stage, the concentrate streams of which feed 2 pressure vessels in a second stage, the concentrate streams of which in turn feed 1 pressure vessel in the third stage. This is designated as a “4:2:1” array. In a staged membrane configuration, the combined permeate streams from all pressure vessels in all stages are collected and used without further membrane treatment. Multi-stage systems are used when large volumes of purified water are required, for example for boiler feed water. The permeate streams from the membrane system may be further purified by ion exchange or other means.

[0068] In a multi-pass system, the permeate streams from each bank of pressure vessels are collected and used as the feed to the subsequent banks of pressure vessels. The concentrate streams from all pressure vessels are combined without further membrane treatment of each individual stream. Multi-pass systems are used when very high purity water is required, for example in the microelectronics or pharmaceutical industries.

[0069] It should be clear from the above examples that the concentrate stream of one stage of an RO system can be the feed stream of another stage. Likewise the permeate stream of a single pass of a multi-pass system may be the feed stream of a subsequent pass. A challenge in monitoring systems such as the reverse osmosis examples cited above is that there are a limited number of places where sampling and monitoring can occur, namely the feed, permeate and concentrate streams. In some, but not all, systems “inter-stage” sampling points allow sampling/monitoring of the first stage concentrate/second stage feed stream. Similar inter-pass sample points may be available on multi-pass systems as well.

[0070] In contrast to cross-flow filtration membrane separation processes, conventional filtration of suspended solids can be conducted by passing a feed fluid through a filter media or membrane in a substantially perpendicular direction. This effectively creates one exit stream during the service cycle. Periodically, the filter is backwashed by passing a clean fluid in a direction opposite to the feed, generating a backwash effluent containing species that have been retained by the filter. Thus conventional filtration produces a feed stream, a purified stream and a backwash stream. This type of membrane separation is typically referred to as dead-end flow separation and is typically limited to the separation of suspended particles greater than about one micron in size.

[0071] Cross-flow filtration techniques can be used for removing smaller particles (generally about one micron in size or less), colloids and dissolved solutes. Such types of cross-flow membrane separation systems can include, for example, reverse osmosis, microfiltration, ultrafiltration, nanofiltration, electrodialysis or the like. Reverse osmosis can remove even low molecular weight dissolved species that are at least about 0.0001 to about 0.001 microns in minimum diameter, including, for example, ionic and nonionic species, low molecular weight molecules, water-soluble macromolecules or polymers, suspended solids, colloids, and such substances as bacteria and viruses.

[0072] In this regard, reverse osmosis is often used commercially to treat water that has a moderate to high (e.g., 500 ppm or greater) total dissolved solids (“TDS”) content. Typically on order of from about 2 percent to about 5 percent of the TDS of a feed stream will pass through the membrane. Thus, in general the permeate may not be entirely free of solutes. In this regard, the TDS of reverse osmosis permeates may be too high for some industrial applications, such as use as makeup water for high pressure boilers. Therefore, reverse osmosis systems and other like membrane separation systems are frequently used prior to and in combination with an ion exchange process or other suitable process to reduce the TDS loading on the resin and to decrease the amount of hazardous material used and stored for resin regeneration, such as acids and sodium hydroxide.

[0073] As discussed above, the performance of membrane separation systems can vary with respect to a number of different operational conditions specific to membrane separation, such as temperature, pH, pressure, permeate flow, activity of treatment and/or cleaning agents, fouling activity and the like. When developing and/or implementing a monitoring and/or control program based on the detection of inert fluorescent tracers, the effects of the operational conditions specific to membrane separation must necessarily be taken into consideration. As previously discussed, the operational conditions of water treatment processes can vary greatly from process to process. In this regard, the monitoring techniques as applied to each process can vary greatly.

[0074] Membrane separation processes and the monitoring thereof are unique because of the following considerations.

[0075] 1. Systems are constructed with limited flexibility in terms of where monitoring may be done and/or where samples may be collected.

[0076] 2. Membrane separation systems include a concentration polarization layer that forms as water is permeated through the barrier. This is not present in other water treatment systems, such as cooling water systems.

[0077] 3. Membrane separation systems operate at significantly lower temperatures than industrial processes where inverse solubility of solutes is a problem. However, in the case of membrane separation systems such as reverse osmosis and nanofiltration, this low temperature leads to scaling from salts that are less likely to be problematic in higher temperature processes (such as silica and silicate salts). In this regard, typical day-to-day membrane separation operations (for example RO and NF) occur at about 75° F.

[0078] 4. Because it is essential that the surface of the membrane remain clean, a relatively small amount of fine precipitate can cause a significant performance loss. The performance loss in a membrane is, thus, more sensitive to precipitate deposition as compared to cooling water treatment. In this regard, performance loss in a membrane can occur at a film thickness appreciably lower than that required for heat transfer loss to occur in a cooling water system.

[0079] 5. Water loss in membrane filtration is due to “permeation” or passage through the membrane barrier. Damaged or otherwise imperfect membranes are susceptible to undesirable leakage of solutes through the membrane. Thus it is critical to monitor leakage through the membrane to keep it operating at maximum efficiency.

[0080] 6. The thin, semi-permeable films (polymeric, organic or inorganic) are sensitive to degradation by chemical species. Products which contact the membranes surface must be compatible with the membrane chemistry to avoid damaging the surface and thereby degrading performance.

[0081] 7. Chemical treatments used in membrane systems must be demonstrated to be compatible with the membrane material prior to use. Damage from incompatible chemicals can result in immediate loss of performance and perhaps degradation of the membrane surface. Such immediate, irreversible damages from a chemical treatment is highly uncommon in cooling water systems.

[0082] As previously discussed, the methods and systems of the present invention employ inert fluorescent tracers to monitor and/or control the membrane separation processes. By using inert tracers, the present invention can evaluate a number of different membrane separation process parameters with a greater selectivity and sensitivity as compared to conventional monitoring techniques. In this regard, the measurable amount of inert tracers can be effectively used to optimally maximize the performance of such systems.

[0083] The term “inert,” as used herein refers to an inert fluorescent tracer that is not appreciably or significantly affected by any other chemistry in the system, or by the other system parameters such as pH, temperature, ionic strength, redox potential, microbiological activity or biocide concentration. To quantify what is meant by “not appreciably or significantly affected”, this statement means that an inert fluorescent compound has no more than a 10% change in its fluorescent signal, under severe conditions encountered in industrial water systems. Severe conditions normally encountered in industrial water systems are known to people of ordinary skill in the art of industrial water systems.

[0084] It should be appreciated that a variety of different and suitable inert tracers can be used in any suitable amount, number and application. For example, a single tracer can be used to evaluate a number of different membrane separation process parameters. However, the present invention can include the use of a number of different tracers each functioning as tracers for separate monitoring applications. In an embodiment, inert fluorescent tracer monitoring of the present invention can be conducted on a singular, intermittent or semi-continuous basis, and preferably the concentration determination of the tracer in the stream is conducted on-site to provide a rapid real-time determination.

[0085] An inert tracer must be transportable with the water of the membrane separation system and thus substantially, if not wholly, water-soluble therein at the concentration it is used, under the temperature and pressure conditions specific and unique to the membrane separation system. In other words, an inert tracer displays properties similar to a solute of the membrane separation process in which it is used. In an embodiment, it is preferred that the inert tracer of the present invention meet the following criteria:

[0086] 1. Not be adsorbed by the membrane in any appreciable amount;

[0087] 2. Not degrade the membrane or otherwise hinder its performance or alter its composition;

[0088] 3. Be detectable on a continuous or semi-continuous basis and susceptible to concentration measurements that are accurate, repeatable and capable of being performed on feedwater, concentrate water, permeate water (should the inert fluorescent tracer be capable of passing through the pores of the membrane) or other suitable media or combinations thereof;

[0089] 4. Be substantially foreign to the chemical species that are normally present in the water of the membrane separation systems in which the inert tracer(s) may be used;

[0090] 5. Be substantially impervious to interference from, or biasing by, the chemical species that are normally present in the water of membrane separation systems in which the inert tracer(s) may be used;

[0091] 6. Be substantially impervious to any of its own potential specific or selective losses from the water of membrane separation systems, including selective permeation of the membrane;

[0092] 7. Be compatible with all treatment agents employed in the water of the membrane separation systems in which the inert tracer(s) may be used, and thus in no way reduce the efficacy thereof;

[0093] 8. Be compatible with all components of its formulation; and

[0094] 9. Be relatively nontoxic and environmentally safe, not only within the environs of the water or the membrane separation process in which it may be used, but also upon discharge therefrom.

[0095] Persons of ordinary skill in the art of membranes know how to set up and run the routine tests necessary to determine whether a particular inert fluorescent tracer is capable of passing through the pores in a membrane. It is required, in order to optimally conduct the method of the first aspect of the instant claimed invention that it is known, in advance, whether the inert fluorescent tracer to be used is capable of passing through the pores of the membrane.

[0096] It should be appreciated that for reverse osmosis membranes the preferred inert tracers of the present invention, substantially have a rejection factor of 1, and more preferably are employed in minute concentrations. Thus, the use of the inert tracer of the present invention does not in any significant manner add to the total dissolved solids (“TDS”) of the permeate nor detrimentally effect a downstream ion exchange process or other permeate polishing process.

[0097] For other types of membranes it should be appreciated that the selection of the inert tracer so that it is known in advance whether the inert tracer is capable of passing through the membrane is the controlling factor. For some membrane systems, an inert tracer that does not pass through the membrane will be desired; for other membrane systems, an inert tracer that is capable of passing through the membrane will be desired. It is even possible to select an inert tracer that allows for partial rejection by the membrane. People of ordinary skill in the art of membranes and inert fluorescent tracers know how to make the determination as to whether an inert fluorescent tracer is capable of passing through a particular membrane.

[0098] It should be appreciated that the amount of inert tracer to be added to the membrane separation process that is effective without being grossly excessive can vary with respect to a variety of factors including, without limitation, the monitoring method selected, the extent of background interference associated with the selected monitoring method, the magnitude of the expected inert tracer(s) concentration in the feedwater and/or concentrate, the monitoring mode (such as, an on-line continuous monitoring mode), and other similar factors. In an embodiment, the dosage of an inert tracer added to the membrane separation system includes an amount that is at least sufficient to provide a measurable concentration in, for example, the concentrate stream, at steady state of at least about 5 parts per trillion (hereinafter “ppt”), and preferably at least about 1 parts per billion (hereinafter “ppb”) or about 5 ppb or higher, such as, up to about 100 parts per million (hereinafter “ppm”) or about 200 ppm, or even as high as about 1000 ppm in the concentrate or other effluent stream. In an embodiment, the amount of tracer ranges from about 5 ppt to about 1000 ppm, preferably from about 1 ppb to about 50 ppm, more preferably from about 5 ppb to about 50 ppb.

[0099] In an embodiment, the inert tracer can be added to a membrane separation system as a component of a formulation, rather than as a separate component, such as a dry solid or neat liquid. The inert tracer formulation or product may include an aqueous solution or other substantially homogeneous mixture that disperses with reasonable rapidity in the membrane separation system to which it is added. In this regard, the inert tracer's concentration may be correlated to the concentration of a product. In an embodiment, the product or formulation can include a treatment agent which is added to treat scaling and/or fouling.

[0100] A variety of different and suitable types of compounds can be used as inert fluorescent tracers. In an embodiment, the inert fluorescent compounds can include, for example, the following compounds:

[0101] 3,6-acridinediamine, N,N,N′,N′-tetramethyl-, monohydrochloride, also known as Acridine Orange (CAS Registry No. 65-61-2),

[0102] 2-anthracenesulfonic acid sodium salt (CAS Registry No. 16106-40-4),

[0103] 1,5-anthracenedisulfonic acid (CAS Registry No. 61736-91-2) and salts thereof,

[0104] 2,6-anthracenedisulfonic acid (CAS Registry No. 61736-95-6) and salts thereof,

[0105] 1,8-anthracenedisulfonic acid (CAS Registry No. 61736-92-3) and salts thereof,

[0106] anthra[9,1,2-cde]benzo[rst]pentaphene-5,10-diol, 16,17-dimethoxy-, bis(hydrogen sulfate), disodium salt, also known as Anthrasol Green IBA (CAS Registry No. 2538-84-3, aka Solubilized Vat Dye)*,

[0107] bathophenanthrolinedisulfonic acid disodium salt (CAS Registry No. 52746-49-3),

[0108] amino 2,5-benzene disulfonic acid (CAS Registry No. 41184-20-7),

[0109] 2-(4-aminophenyl)-6-methylbenzothiazole (CAS Registry No. 92-36-4),

[0110] 1H-benz[de]isoquinoline-5-sulfonic acid, 6-amino-2,3-dihydro-2-(4-methylphenyl)-1,3-dioxo-, monosodium salt, also known as Brilliant Acid Yellow 8G (CAS Registry No. 2391-30-2, aka Lissamine Yellow FF, Acid Yellow 7)*,

[0111] phenoxazin-5-ium, 1-(aminocarbonyl)-7-(diethylamino)-3,4-dihydroxy-, chloride, also known as Celestine Blue (CAS Registry No. 1562-90-9)*,

[0112] benzo[a]phenoxazin-7-ium, 5,9-diamino-, acetate, also known as cresyl violet acetate (CAS Registry No. 10510-54-0)*,

[0113] 4-dibenzofuransulfonic acid (CAS Registry No. 42137-76-8),

[0114] 3-dibenzofuransulfonic acid (CAS Registry No. 215189-98-3),

[0115] 1-ethylquinaldinium iodide (CAS Registry No. 606-53-3)*,

[0116] fluorescein (CAS Registry No. 2321-07-5)*,

[0117] fluorescein, sodium salt (CAS Registry No. 518-47-8, aka Acid Yellow 73, Uranine)*,

[0118] Keyfluor White ST (CAS Registry No. 144470-48-4, aka Flu. Bright 28),

[0119] benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4-[bis(2-hydroxyethyl)amino]-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-, tetrasodium salt, also known as Keyfluor White CN (CAS Registry No. 16470-24-9),

[0120] C.I. Fluorescent Brightener 230, also known as Leucophor BSB (CAS Registry No. 68444-86-0),

[0121] benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4-[bis(2-hydroxyethyl)amino]-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-, tetrasodium salt, also known as Leucophor BMB (CAS Registry No. 16470-24-9, aka Leucophor U, Flu. Bright. 290),

[0122] 9,9′-biacridinium, 10,10′-dimethyl-, dinitrate, also known as Lucigenin (CAS Registry No. 2315-97-1, aka bis-N-methylacridinium nitrate)*,

[0123] 1-deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo [g]pteridin-10(2H)-yl)-D-ribitol, also known as Riboflavin or Vitamin B2 (CAS Registry No. 83-88-5),

[0124] mono-, di-, or tri-sulfonated napthalenes, including but not limited to

[0125] 1,5-naphthalenedisulfonic acid, disodium salt (hydrate) (CAS Registry No. 1655-29-4, aka 1,5-NDSA hydrate),

[0126] 2-amino-1-naphthalenesulfonic acid (CAS Registry No. 81-16-3),

[0127] 5-amino-2-naphthalenesulfonic acid (CAS Registry No. 119-79-9),

[0128] 4-amino-3-hydroxy-1-naphthalenesulfonic acid (CAS Registry No. 90-51-7),

[0129] 6-amino-4-hydroxy-2-naphthalenesulfonic acid (CAS Registry No. 116-63-2),

[0130] 7-amino-1,3-naphthalenesulfonic acid, potassium salt (CAS Registry No. 79873-35-1),

[0131] 4-amino-5-hydroxy-2,7-naphthalenedisulfonic acid (CAS Registry No. 90-20-0),

[0132] 5-dimethylamino-1-naphthalenesulfonic acid (CAS Registry No. 4272-77-9),

[0133] 1-amino-4-naphthalene sulfonic acid (CAS Registry No. 84-86-6),

[0134] 1-amino-7-naphthalene sulfonic acid (CAS Registry No. 119-28-8), and

[0135] 2,6-naphthalenedicarboxylic acid, dipotassium salt (CAS Registry No. 2666-06-0),

[0136] 3,4,9,10-perylenetetracarboxylic acid (CAS Registry No. 81-32-3)*,

[0137] C.I. Fluorescent Brightener 191, also known as Phorwite CL (CAS Registry No. 12270-53-0),

[0138] C.I. Fluorescent Brightener 200, also known as Phorwite BKL (CAS Registry No. 61968-72-7),

[0139] benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-(4-phenyl-2H-1,2,3-triazol-2-yl)-, dipotassium salt, also known as Phorwite BHC 766 (CAS Registry No. 52237-03-3),

[0140] benzenesulfonic acid, 5-(2H-naphtho[1,2-d]triazol-2-yl)-2-(2-phenylethenyl)-, sodium salt, also known as Pylaklor White S-15A (CAS Registry No. 6416-68-8),

[0141] 1,3,6,8-pyrenetetrasulfonic acid, tetrasodium salt (CAS Registry No. 59572-10-0),

[0142] pyranine, (CAS Registry No. 6358-69-6, aka 8-hydroxy-1,3,6-pyrenetrisulfonic acid, trisodium salt)*,

[0143] quinoline (CAS Registry No. 91-22-5),

[0144] 3H-phenoxazin-3-one, 7-hydroxy-, 10-oxide, also known as Rhodalux (CAS Registry No. 550-82-3)*,

[0145] xanthylium, 9-(2,4-dicarboxyphenyl)-3,6-bis(diethylamino)-, chloride, disodium salt, also known as Rhodamine WT (CAS Registry No. 37299-86-8)*,

[0146] phenazinium, 3,7-diamino-2,8-dimethyl-5-phenyl-, chloride, also known as Safranine 0 (CAS Registry No. 477-73-6)*,

[0147] C.I. Fluorescent Brightener 235, also known as Sandoz CW (CAS Registry No. 56509-06-9),

[0148] benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4-[bis(2-hydroxyethyl)amino]-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-, tetrasodium salt, also known as Sandoz CD (CAS Registry No. 16470-24-9, aka Flu. Bright. 220),

[0149] benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis [5-[[4-[(2-hydroxypropyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt, also known as Sandoz TH-40 (CAS Registry No. 32694-95-4),

[0150] xanthylium, 3,6-bis(diethylamino)-9-(2,4-disulfophenyl)-, inner salt, sodium salt, also known as Sulforhodamine B (CAS Registry No. 3520-42-1, aka Acid Red 52)*,

[0151] benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4-[(aminomethyl)(2-hydroxyethyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt, also known as Tinopal 5BM-GX (CAS Registry No. 169762-28-1),

[0152] Tinopol DCS (CAS Registry No. 205265-33-4),

[0153] benzenesulfonic acid, 2,2′-([1,1′-biphenyl]-4,4′-diyldi-2,1-ethenediyl)bis-, disodium salt also known as Tinopal CBS-X (CAS Registry No. 27344-41-8),

[0154] benzenesulfonic acid, 5-(2H-naphtho[1,2-d]triazol-2-yl)-2-(2-phenylethenyl)-, sodium salt, also known as Tinopal RBS 200, (CAS Registry No. 6416-68-8),

[0155] 7-benzothiazolesulfonic acid, 2,2′-(1-triazene-1,3-diyldi-4,1-phenylene)bis[6-methyl-, disodium salt, also known as Titan Yellow (CAS Registry No. 1829-00-1, aka Thiazole Yellow G)*, and

[0156] all ammonium, potassium and sodium salts thereof, and all like agents and suitable mixtures thereof.

[0157] Those inert fluorescent tracers marked with an asterisk *, are known to display a visible color at the higher concentration levels. This “visible color” consideration is not dispositive in selection of the inert fluorescent tracers, however, it is a consideration for those systems where visible color is not desirable. Persons of ordinary skill in the art know how to select inert fluorescent tracers so the absence or presence of visible color can be dealt with.

[0158] Preferred tracers include:

[0159] 1-deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10(2H)-yl)-D-ribitol, also known as Riboflavin or Vitamin B2 (CAS Registry No. 83-88-5),

[0160] fluorescein (CAS Registry No. 2321-07-5),

[0161] fluorescein, sodium salt (CAS Registry No. 518-47-8, aka Acid Yellow 73, Uranine),

[0162] 2-anthracenesulfonic acid sodium salt (CAS Registry No. 16106-40-4),

[0163] 1,5-anthracenedisulfonic acid (CAS Registry No. 61736-91-2) and salts thereof,

[0164] 2,6-anthracenedisulfonic acid (CAS Registry No. 61736-95-6) and salts thereof,

[0165] 1,8-anthracenedisulfonic acid (CAS Registry No. 61736-92-3) and salts thereof,

[0166] mono-, di-, or tri-sulfonated napthalenes, including but not limited to

[0167] 1,5-naphthalenedisulfonic acid, disodium salt (hydrate) (CAS Registry No. 1655-29-4, aka 1,5-NDSA hydrate),

[0168] 2-amino-1-naphthalenesulfonic acid (CAS Registry No. 81-16-3),

[0169] 5-amino-2-naphthalenesulfonic acid (CAS Registry No. 119-79-9),

[0170] 4-amino-3-hydroxy-1-naphthalenesulfonic acid (CAS Registry No. 90-51-7),

[0171] 6-amino-4-hydroxy-2-naphthalenesulfonic acid (CAS Registry No. 116-63-2),

[0172] 7-amino-1,3-naphthalenesulfonic acid, potassium salt (CAS Registry No. 79873-35-1),

[0173] 4-amino-5-hydroxy-2,7-naphthalenedisulfonic acid (CAS Registry No. 90-20-0),

[0174] 5-dimethylamino-1-naphthalenesulfonic acid (CAS Registry No. 4272-77-9),

[0175] 1-amino-4-naphthalene sulfonic acid (CAS Registry No. 84-86-6),

[0176] 1-amino-7-naphthalene sulfonic acid (CAS Registry No. 119-28-8), and

[0177] 2,6-naphthalenedicarboxylic acid, dipotassium salt (CAS Registry No. 2666-06-0),

[0178] 3,4,9,10-perylenetetracarboxylic acid (CAS Registry No. 81-32-3),

[0179] C.I. Fluorescent Brightener 191, also known as, Phorwite CL (CAS Registry No. 12270-53-0),

[0180] C.I. Fluorescent Brightener 200, also known as Phorwite BKL (CAS Registry No. 61968-72-7),

[0181] benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-(4-phenyl-2H-1,2,3-triazol-2-yl)-, dipotassium salt, also known as Phorwite BHC 766 (CAS Registry No. 52237-03-3),

[0182] benzenesulfonic acid, 5-(2H-naphtho[1,2-d]triazol-2-yl)-2-(2-phenylethenyl)-, sodium salt, also known as Pylaklor White S-15A (CAS Registry No. 6416-68-8),

[0183] 1,3,6,8-pyrenetetrasulfonic acid, tetrasodium salt (CAS Registry No. 59572-10-0),

[0184] pyranine, (CAS Registry No. 6358-69-6, aka 8-hydroxy-1,3,6-pyrenetrisulfonic acid, trisodium salt),

[0185] quinoline (CAS Registry No. 91-22-5),

[0186] 3H-phenoxazin-3-one, 7-hydroxy-, 10-oxide, also known as Rhodalux (CAS Registry No. 550-82-3),

[0187] xanthylium, 9-(2,4-dicarboxyphenyl)-3,6-bis(diethylamino)-, chloride, disodium salt, also known as Rhodamine WT (CAS Registry No. 37299-86-8),

[0188] phenazinium, 3,7-diamino-2,8-dimethyl-5-phenyl-, chloride, also known as Safranine 0 (CAS Registry No. 477-73-6),

[0189] C.I. Fluorescent Brightener 235, also known as Sandoz CW (CAS Registry No. 56509-06-9),

[0190] benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4-[bis(2-hydroxyethyl)amino]-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-, tetrasodium salt, also known as Sandoz CD (CAS Registry No. 16470-24-9, aka Flu. Bright. 220),

[0191] benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4-[(2-hydroxypropyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt, also known as Sandoz TH-40 (CAS Registry No. 32694-95-4),

[0192] xanthylium, 3,6-bis(diethylamino)-9-(2,4-disulfophenyl)-, inner salt, sodium salt, also known as Sulforhodamine B (CAS Registry No. 3520-42-1, aka Acid Red 52),

[0193] benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4-[(aminomethyl)(2-hydroxyethyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt, also known as Tinopal 5BM-GX (CAS Registry No. 169762-28-1),

[0194] Tinopol DCS (CAS Registry No. 205265-33-4),

[0195] benzenesulfonic acid, 2,2′-([1,1′-biphenyl]-4,4′-diyldi-2,1-ethenediyl)bis-, disodium salt, also known as Tinopal CBS-X (CAS Registry No. 27344-41-8),

[0196] benzenesulfonic acid, 5-(2H-naphtho[1,2-d]triazol-2-yl)-2-(2-phenylethenyl)-, sodium salt, also known as Tinopal RBS 200, (CAS Registry No. 6416-68-8),

[0197] 7-benzothiazolesulfonic acid, 2,2′-(1-triazene-1,3-diyldi-4,1-phenylene)bis [6-methyl-, disodium salt, also known as Titan Yellow (CAS Registry No. 1829-00-1, aka Thiazole Yellow G), and all ammonium, potassium and sodium salts thereof, and all like agents and suitable mixtures thereof.

[0198] The most preferred fluorescent inert tracers of the present invention include 1,3,6,8-pyrenetetrasulfonic acid tetrasodium salt (CAS Registry No. 59572-10-0); 1,5-naphthalenedisulfonic acid disodium salt (hydrate) (CAS Registry No. 1655-29-4, aka 1,5-NDSA hydrate); xanthylium, 9-(2,4-dicarboxyphenyl)-3,6-bis(diethylamino)-, chloride, disodium salt, also known as Rhodamine WT (CAS Registry No. 37299-86-8); 1-deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10(2H)-yl)-D-ribitol, also known as Riboflavin or Vitamin B2 (CAS Registry No. 83-88-5); fluorescein (CAS Registry No. 2321-07-5); fluorescein, sodium salt (CAS Registry No. 518-47-8, aka Acid Yellow 73, Uranine); 2-anthracenesulfonic acid sodium salt (CAS Registry No. 16106-40-4); 1,5-anthracenedisulfonic acid (CAS Registry No. 61736-91-2) and salts thereof; 2,6-anthracenedisulfonic acid (CAS Registry No. 61736-95-6) and salts thereof; 1,8-anthracenedisulfonic acid (CAS Registry No. 61736-92-3) and salts thereof; and mixtures thereof. The fluorescent tracers listed above are commercially available from a variety of different chemical supply companies.

[0199] In addition to the tracers listed above, those skilled in the art will recognize that salts using alternate counter ions may also be used. Thus, for example, anionic tracers which have Na+ as a counter ion could also be used in forms where the counter ion is chosen from the list of: K+, Li+, NH4+, Ca+2, Mg+2 or other appropriate counter ions. In the same way, cationic tracers may have a variety of counter ions, for example: Cl−, So4−2, PO4−3, HPO4−2; H2PO4−; CO3−2; HCO3−; or other appropriate counter ions.

[0200] Modifications of these tracers to control molecular weight or physical size within a desirable size range by, for example, affixing them to an inert polymeric molecule, incorporating them into a fluorescent microsphere or adding additional chemical moieties in the side chains of the molecules should be obvious to those skilled in the art. Such modifications are included herein. It is important to reiterate that after modification the modified inert tracer should be tested to see if it is capable of passing through the pores of the membrane in the membrane system.

[0201] As previously discussed, the inert tracer(s) is measured or detected to evaluate the performance of the membrane separation process. A determination of the presence of an inert fluorescent tracer and the concentration thereof in the influent/feedwater and/or other process stream of a membrane separation process can be made when the concentration of the inert tracer in the influent/feedwater and/or other stream of a membrane separation system is several parts per million or less, even as low as parts per billion as previously discussed.

[0202] At times, it may be desired to employ a number of inert tracers. In this regard, it may be desired to use a number of inert tracers to monitor, for example, inert tracer-specific losses, variances, like conditions or combinations thereof. Such separate and distinct inert tracers can each be detected and quantified in a single influent/feedwater and/or other stream fraction despite both being inert fluorescent tracers provided that their respective wavelengths of emission do not interfere with one another. Thus, concurrent analyses for multiple inert tracers is possible by selection of inert tracers that have appropriate spectral characteristics.

[0203] The inert tracers of the present invention can be detected by using a variety of different and suitable techniques. For example, fluorescence emission spectroscopy on a substantially continuous basis, at least over a given time period, is one of the preferred analytical techniques according to an embodiment of the present invention. One method for the continuous on-stream measuring of chemical tracers by fluorescence emission spectroscopy and other analysis methods is described in U.S. Pat. No. 4,992,380, B. E. Moriarty, J. J. Hickey, W. H. Hoy, J. E. Hoots and D. A. Johnson, issued Feb. 12, 1991, incorporated hereinto by reference.

[0204] In general, for most fluorescence emission spectroscopy methods having a reasonable degree of practicality, it is preferable to perform the analysis without isolating in any manner the tracer(s). Thus, there may be some degree of background fluorescence in the influent/feedwater and/or concentrate on which the fluorescence analysis is conducted. This background fluorescence may come from chemical compounds in the membrane separation system (including the influent/feedwater system thereof) that are unrelated to the membrane separation process of the present invention.

[0205] In instances where the background fluorescence is low, the relative measurable intensities (measured against a standard fluorescent compound at a standard concentration and assigned a relative intensity, for instance 100) of the fluorescence of the inert tracer versus the background can be very high, for instance a ratio of 100/10 or 500/10, when certain combinations of excitation and emission wavelengths are employed even at low fluorescent compound concentrations. Such ratios would be representative of a “relative fluorescence” (under like conditions) of respectively 10 and 50. In an embodiment, the excitation/emission wavelengths and/or the amount of inert tracer employed are selected to provide a relative fluorescence of at least about 5 or about 10 for the given background fluorescence anticipated.

[0206] Examples of fluorometers that may be used in the practice of this invention include the TRASAR® 3000 fluorometer, the TRASAR® 8000 fluorometer and the TRASAR® XE-2 Controller, which includes a fluorometer with integrated controller, all available from Nalco; the Hitachi F-4500 fluorometer (available from Hitachi through Hitachi Instruments Inc. of San Jose, Calif.); the JOBIN YVON FluoroMax-3 “SPEX” fluorometer (available from JOBIN YVON Inc. of Edison, N.J.); and the Gilford Fluoro-IV spectrophotometer or the SFM 25 (available from Bio-tech Kontron through Research Instruments International of San Diego, Calif.). It should be appreciated that the fluorometer list is not comprehensive and is intended only to show examples of fluorometers. Other commercially available fluorometers and modifications thereof can also be used in this invention.

[0207] After the fluorometer has been used to detect the fluorescent signal of the inert fluorescent tracer then the detected fluorescent signal can be converted into the actual concentration of inert fluorescent tracer using graphs that show what the detected fluorescent signal is for a specific amount of a specific inert fluorescent tracer. These graphs are known to people of ordinary skill in the art of fluorometry.

[0208] In an embodiment, the monitoring of the membrane filtration process of the present invention can be based on a measurable amount of the inert tracer from at least one of the feedwater stream, the concentrate stream and optionally in the permeate stream, when an inert fluorescent tracer is chosen to be used that is capable of passing through the pores of the membrane.

[0209] For example, when the parameter of interest is the percent rejection (discussed below), it is believed that the most sensitive determinations are of the feedwater inert tracer concentration and the permeate inert tracer concentration (which will be zero if an inert tracer has been chosen that is not capable of passing through the pores of the membrane thus making the percent rejection be 100 percent). The percent rejection parameter, that is, the percent of solute that has been rejected or has not passed through the membrane, can be determined by the following relationships:

CR=CB/CF=F/B  Equation 1

F=P[CR/(CR−1)]  Equation 2

CR=[1/(1−R)]  Equation 3

[0210] where CF is the concentration of solute in the feed stream (e.g., combined fresh feed fluid and recycled feed fluid); CP is the concentration of solute in the permeate as discharged through; CB is the concentration of solute in the concentrate water as discharged through; F is the feed stream flow rate in gal/min; P is the permeate discharge flow rate in gal/min; B is the concentrate water flow rate; L is the recycle rate; R is the recovery ratio (e.g., P/F); and CR is the concentration ratio, (e.g., CB/CF).

[0211] When there is less than complete rejection of a solute, for instance only 80 percent rejection (e.g., a 0.8 rejection factor), CR will be less than F/B as shown in Equation 4:

CR=(F/B)×rejection factor  Equation 4

[0212] The rejection factor again is the measure of the extent of solute rejection by the membrane, as calculated in Equation 5, wherein CF is the concentration of solute in the feedwater and CP is the concentration of solute in the permeate:

rejection factor=(CF−CP)/CF  Equation 5

[0213] The same equations will apply in a traced stream (e.g., a stream that contains an inert tracer(s)) wherein “tracer-C” (e.g., tracer-CF, tracer-CP and tracer-CB) is substituted for CF, CP and CB in equations 1-5. When there is less than complete rejection of an inert tracer, for instance only 80 percent rejection (a 0.8 rejection factor), tracer-CR will be less than F/B as shown in Equation 4. In this regard, the determination of the rejection of the inert tracer in the membrane filtration system is at least proportional to the rejection of the solute within same. In a preferred embodiment for most reverse osmosis membranes, the percent rejection is determined and maintained at an amount ranging from about 95 to about 100 percent.

[0214] In this regard, monitoring of an amount of the inert tracer as it may vary during membrane filtration can be used to evaluate a number of process parameters specific to membrane filtration such as a percent recovery, percent rejection, recovery ratio or the like, with a high degree of sensitivity, selectivity and accuracy, as previously discussed. The ability to evaluate these types of membrane separation process parameters with such level of certainty, sensitivity and selectivity and on a continual basis in accordance with the present invention can provide a better understanding, in real time, of the performance of the membrane. Thus, adjustments to the membrane separation process can be made more responsively and effectively based on the measured amount of the inert tracer, if needed, to optimize membrane performance. For example, adjustments can be made to increase the recovery ratio or percent recovery of the membrane separation system. In this regard, increasing the recovery ratio or percent recovery, for unit product, will reduce the feedwater required and thus reduce feedwater costs, lower influent fluid pretreatment costs and chemical treatment requirements. It should be appreciated that the optimal percent rejection value can vary with respect to the type of membrane separation system. In addition, percent recovery may be calculated in various ways. In membrane filtration the percent recovery calculation can be based on ratios of the various streams or on concentrations of solutes within those streams. In this regard, the amount of inert tracer in the various streams can provide an accurate assessment of percent recovery as well as a method for checking the calibration of the mechanical flow sensors in the system.

[0215] It should be appreciated that the present invention can be used to assess and/or control a variety of different conditions that may have an impact on the performance of the membrane separation process. For example, the present invention can be used to monitor leaks in the membrane elements. This is very important to the practical operation of a membrane separation system. Leaks are universally regarded as being “bad” and “undesirable” from the standpoint of optimal operation of a membrane separation system.

[0216] In this regard, leakage of concentrate through a membrane itself or a component of the membrane element contaminates the permeate. Permeate contamination by virtue of leakage may at times be so severe that the performance of the membrane separation process is substantially impaired, and at best the quality of the permeate is diminished. Upon such leakage there will be an increase in the normalized permeate flow and permeate solute concentrations, but the increases may be minor and most probably not be detected for at least a number of hours if conventional monitoring techniques are used.

[0217] The present invention can monitor membrane leakage with a high degree of sensitivity, selectivity and/or accuracy and that can be readily conducted on a continuous basis. When the inert fluorescent tracer monitoring of the present invention is used to monitor the permeate, particularly on a continuous or substantially continuous basis, an increase in permeate inert tracer concentration can be readily detected to signal that leakage is likely to be occurring. In addition, the detection of an increase in the concentration of permeate inert tracer would follow the onset of the leakage almost instantaneously.

[0218] In a preferred embodiment, the combination of the chemical compound(s) selected as the inert tracer(s) and the analytical technique selected for determining the presence of such inert tracer(s), permits such determination without isolation of the inert tracer(s), and more preferably should permit such determination on a continuous and/or on-line basis.

[0219] In an embodiment, the present invention includes a controller to monitor and/or control the operating conditions and the performance of the membrane separation process based on the measurable amount of inert fluorescent tracer(s). The controller can be configured and/or adjusted in a variety of different and suitable ways. Controllers suitable for this purpose are commercially available from Nalco Company of Naperville Ill.

[0220] The controller can be in contact with the detection device to process the detection signal, for example, to filter noise from the signal in order to enhance the detection of the inert tracer. Further, the controller can be adjusted to communicate with other components of the membrane separation system. The communication can be either hard wired, for example, with an electrical communication cable, a wireless communication, for example with a wireless RF interface, a pneumatic interface or any known suitable communication means.

[0221] In this regard, the controller can be used to control the performance of membrane separation. For example, the controller can communicate with a feed device (not shown) in order to control the dosage of treatment agents, such as antiscalants and biocides, within the membrane separation process. In an embodiment, the controller is capable of adjusting the feed rate of the feed stream based on the amount of inert tracer that is measured.

[0222] It should be appreciated that pairs or groups of inert tracer monitoring points that are to be compared should not be positioned across a flow-through site that has a high concentration of solids, for instance a solids concentration of at least about 5 or about 10 weight percent per unit volume based on a measured volume unit of about one cubic inch. Such high solids concentration flow-through sites are found at the site of filter cakes and the like. In this regard, these sites may absorb, or selectively absorb, at least some amount of the inert tracer. This can distort the significance of monitoring comparison. When an inert tracer is added upstream of, for instance, a cartridge filter, in an embodiment, the first monitoring location of a monitoring pair should preferably be downstream of such sites.

[0223] However, separate monitorings across a flow-through site of high solids concentration may be conducted to determine the loss of an inert tracer from the fluid, and if such loss is nonselective for the inert tracer, the loss of other solutes at that site. For instance, when the flow-through site is a cartridge filter, such monitorings can determine the loss of solutes, if any, attributable to that pretreatment location. Other high solids concentration sites include without limitation sites of solids concentration(s) created by the use of chemical additives such as coagulants, flocculants and the like.

[0224] Although membrane separation systems are often employed for the purification of water, or the processing of aqueous streams, the systems of the present invention are not limited to the use of an aqueous influent. In an embodiment, the influent may be another fluid, or a combination of water and another fluid. The operational principles of membrane separation systems and processes of the present invention are not so governed by the nature of the influent that the present invention could not be employed with influents otherwise suitable for water purification in a given membrane separation system. The descriptions of the invention above that refer to aqueous systems are applicable also to nonaqueous and mixed aqueous/nonaqueous systems.

[0225] It should be appreciated that the present invention is applicable to all industries that can employ membrane separation processes. For example, the different types of industrial water systems in which the method of the present invention can be applied generally include raw water processes, waste water processes, industrial water processes, municipal water treatment, food and beverage processes, pharmaceutical processes, electronic manufacturing, utility operations, pulp and paper processes, mining and mineral processes, transportation-related processes, textile processes, plating and metal working processes, laundry and cleaning processes, leather and tanning processes, and paint processes.

[0226] In particular, food and beverage processes can include, for example, dairy processes relating to the production of cream, low-fat milk, cheese, specialty milk products, protein isolates, lactose manufacture, whey, casein, fat separation, and brine recovery from salting cheese. Uses relating to the beverage industry including, for example, fruit juice clarification, concentration or deacidification, alcoholic beverage clarification, alcohol removal for low-alcohol content beverages, process water; and uses relating to sugar refining, vegetable protein processing, vegetable oil production/processing, wet milling of grain, animal processing (e.g., red meat, eggs, gelatin, fish and poultry), reclamation of wash waters, food processing waste and the like.

[0227] Examples of industrial water uses as applied to the present invention include, for example, boiler water production, process water purification and recycle/reuse, softening of raw water, treatment of cooling water blow-down, reclamation of water from papermaking processes, desalination of sea and brackish water for industrial and municipal use, drinking/raw/surface water purification including, for example, the use of membranes to exclude harmful micro-organisms from drinking water, polishing of softened water, membrane bio-reactors, mining and mineral process waters.

[0228] Examples of waste water treatment applications with respect to the inert tracer monitoring methods of the present invention include, for example, industrial waste water treatment, biological waste treatment systems, removal of heavy metal contaminants, polishing of tertiary effluent water, oily waste waters, transportation related processes (e.g., tank car wash water), textile waste (e.g., dye, adhesives, size, oils for wool scouring, fabric finishing oils), plating and metal working waste, laundries, printing, leather and tanning, pulp and paper (e.g., color removal, concentration of dilute spent sulfite liquor, lignin recovery, recovery of paper coatings), chemicals (e.g., emulsions, latex, pigments, paints, chemical reaction by-products), and municipal waste water treatment (e.g., sewage, industrial waste).

[0229] Other examples of industrial applications of the present invention include, for example, semiconductor rinse water processes, production of water for injection, pharmaceutical water including water used in enzyme production/recovery and product formulation, and electro-coat paint processing.

[0230] Diagnostics which can be determined by the use of inert tracers include, but are not limited to, effective “residence times” for species within the membrane, system flow profiles, membrane damage detection, system recovery based on mass balance, detection of scaling or fouling tendency (based on differences between mass balance and flow based system parameters), system volume calculation, chemical treatment product distribution and feed variability.

EXAMPLES

[0231] The following examples are intended to be illustrative of the present invention and to teach one of ordinary skill how to make and use the invention. These examples are not intended to limit the invention or its protection in any way.

Example 1

[0232] Tests were performed using a multi-stage reverse osmosis system. The system used six pressure vessels, arranged in a 2:2:1:1 configuration with each pressure vessel containing 3 spiral wound membrane elements. The membrane elements were a polyamide based elements from several element manufacturers. Typical system recovery, based on system flows, was 75-80%, with the feed flow ranging from about 100 gpm to about 130 gpm.

[0233] The feed water included an inert fluorescent tracer (an aqueous solution of 1,3,6,8-pyrenetetrasulfonic acid tetrasodium salt (PTSA)), diluted with water to give a final concentration of 0.20 to 0.25% as the active fluorophore in an aqueous solution. The inert tracer was fed into the RO membrane system using a positive displacement pump at a feed rate of approximately 2 milliliters/minute and at a concentration of about 6 ppm into the feed stream described above.

[0234] The concentration of the inert tracer was fluorometrically measured, with a TRASAR® 3000 and/or a TRASAR® 8000 fluorometer, in the RO membrane system in both the feed stream and the concentrate stream over a select period of time, generally one to three hours with data being collected at one second intervals. (Fluorometer readings were expressed as “ppm of treatment product.” The fluorometer was programmed to read the concentration of the tracer and convert the reading into ppm of treatment. In this case, the treatment was assumed to contain 0.2% active fluorophore.) Periodic fluctuations in the concentration of the inert tracer in both of the concentrate and feed streams were continuously detected. The concentration of the inert tracer in the concentrate stream varied from about 40 ppb of tracer (20 ppm as treatment product) to as high as about 180 ppb of tracer (90 ppm as treatment product). In general, the concentration of the inert tracer in the concentrate stream varied between about 40 ppb of tracer (20 ppm as treatment product) and about 80 ppb of tracer (40 ppm as treatment product). In comparison, the concentration of the inert tracer in the feed stream varied from about 10 ppb of tracer (5 ppm as treatment product) or less to as high as about 130 ppb of tracer (65 ppm as treatment product). In general, the concentration of the inert tracer in the feed stream varied from about 10 ppb of tracer (5 ppm as treatment product) or lower to about 20 ppb of tracer (10 ppm as treatment product).

[0235] The ability of the present invention to detect fluctuations in the concentration of the inert tracer added to the membrane separation system uniquely allows the present invention to evaluate process parameters specific to a membrane separation with a high degree of selectivity, sensitivity and/or accuracy such that the performance (e.g., operational, chemical, mechanical and/or the like) of membrane separation can be effectively monitored. In this regard, suitable adjustments can be controllably and responsively made to the membrane separation system such that performance is optimized. For example, the detection of fluctuations in the concentration of the inert fluorescent tracer during membrane separation (as discussed above) may necessarily indicate that suitable and responsive adjustments to the membrane separation process are necessary to decrease the fluctuations, and, thus enhance membrane separation performance.

[0236] The test results also displayed spikes in the concentration of the inert tracer in both of the feed stream and the concentrate stream. As previously discussed, the spike in the amount of inert tracer in the feed stream occurred at about 120 ppb of tracer (60 ppm as treatment product) in comparison to that in the concentrate stream which occurred at about 180 ppb of tracer (90 ppm as treatment product). By measuring the elapsed time between the spikes in both of the feed and concentrate streams, the effective residence time of solutes within the membrane separation system can be calculated. This information can be useful, for example, in developing a treatment strategy specific to membrane separation.

[0237] Furthermore, the tracer was used to calculate percent recovery as described above. Whereas the percent recovery calculations based on flow measurements indicate recoveries of about 75% to about 80%, recovery calculations based on mass balance of the tracer shows significantly higher percent recovery values, of 89%-92%. Inaccuracies in ability to measure flow are believed to account for the majority of the differences in these amounts of recovery.

[0238] Such information is useful in developing effective scale control strategies.

Example 2

[0239] Experiments were performed using thin film composites of a polyamide based reverse osmosis membrane material in order to simulate process conditions using a reverse osmosis membrane separation system.

[0240] In this regard, a number of flat or planar sheets of the membrane were cut from a roll of the polyamide material which is a commercially available product, for example FT30 from FILMTEC of Minneapolis, Minn.

[0241] Tests were performed in a SEPA CF, flat plate reverse osmosis cell which is commercially available from the Osmonics Corporation of Minnetonka, Minn. The test system typically included a feed water tank, a high pressure pump, and the flat plate cell. The system was modified so that the change in pressure across the membrane and the inlet pressure, as well as the feedwater, permeate water, and concentrate water conductivities, and the permeate and concentrate water flows could be continuously monitored. See Table 1. A data logger, available from the Yokogawa Corporation of America of Newnan, Ga., was used to continuously monitor and collect data. Fluorometers (TRASAR® 3000, TRASAR® 8000 and Hitachi F-4500) were used to measure the concentrations of tracers in the systems.

[0242] The experimental test conditions were as follows: 1 NaHCO3 118 ppm (84 ppm as HCO3−) CaCl2 694 ppm (250 ppm as Ca++) MgSO4.7H2O 1281 ppm (125 ppm as Mg++) Na2HPO4 14.9 ppm (10 ppm as PO4−3) pH 8.5

[0243] Permeate was sent to drain and concentrate returned to the feed water tank.

[0244] The test was designed to form scale on the membrane over time, thus decreasing permeate flow.

[0245] Tests were run to show monitoring of the reverse osmosis system with an undamaged membrane. As shown by the calculated performance parameters in Table 2 below, the percent rejection of the tracer was 100%. This indicates that the tracer molecule did not pass through an undamaged membrane. In contrast, a portion of the dissolved salts (as measured by conductivity) did pass through the membrane. 2 TABLE 1 Measured Parameters Tracer Temperature concentrations (ppm) Conductivity (mS) (Degrees) Flow (ml/min) Pressure (psi) feed reject permeate feed reject permeate F. C. reject permeate feed feed reject permeate 0.586 0.647 0.000 4.13 4.83 0.278 64 18 101 16.4 117 380 379 0 0.504 0.570 0.000 4.00 4.66 0.203 70 21 100 19   119 380 379 0 0.429 0.465 0.000 5.49 6.15 0.151 66 19 100 11.8 112 380 379 0

[0246] 3 TABLE 2 Calculated Parameters Percent Rejection Percent Recovery Based on Based on System Various Measures Various Measures Normalized Inert Con- Permeate Avg. Florescent Conduc- duc- Flow Pressure Tracer tivity NPF Tracer tivity (NPF) Drop 100.0 93.3 14.0 9.4 15.4 20 1 100.0 94.9 16.0 11.6  14.8 21 1 100.0 97.2 10.6 7.7 11.0 14 1

[0247] Calculated parameters were calculated using industry standards known to persons of ordinary skill in the art, as understood at the time of filing of this patent application.

[0248] Another sheet of polyamide membrane material was damaged by swabbing the surface with a 0.05% hypochlorite solution. Using a feed solution of 1500 ppm NaCl, rejection of the tracer molecule was monitored. All other experimental conditions were the same as above. The results shown in Table 4 indicate significant passage of the tracer through the damaged membrane. Since conductive salts pass through both undamaged, see Table 2, and damaged, see Table 3, membranes, the tracer only passes through damaged membranes, making tracer measurement a more sensitive indicator of membrane damage than conductivity measurements. 4 TABLE 3 Measured Parameters Tracer Temperature concentrations (ppm) Conductivity (mS) (Degrees) Flow (ml/min) Pressure (psi) feed reject permeate feed reject permeate F. C. reject permeate feed feed reject permeate 0.604 0.633 0.000 5.02 5.25 0.182 77 25 242 13.9 256 380 379 0 0.605 0.655 0.140 5.02 5.36 1.470 73 23 177 16.5 194 380 379 0 0.605 0.655 0.081 5.02 5.36 0.970 73 23 176 15.7 192 380 379 0

[0249] 5 TABLE 4 Calculated Parameters Percent Rejection Percent Recovery Based on Based on System Various Measures Various Measures Normalized Inert Con- Permeate Avg. Florescent Conduc- duc- Flow Pressure Tracer tivity NPF Tracer tivity (NPF) Drop 100.0 96.4 5.4 4.6 4.5 14 1 76.9 70.7 8.5 9.7 8.7 18 1 86.6 80.7 8.2 8.7 7.7 17 1

[0250] While the present invention is described above in connection with preferred or illustrative embodiments, these embodiments are not intended to be exhaustive or limiting of the invention. Rather, the invention is intended to cover all alternatives, modifications and equivalents included within its spirit and scope, as defined by the appended claims.

Claims

1. A method of monitoring a membrane separation process including a membrane capable of separating a feed stream into at least a first stream, known as the concentrate, and a second stream, known as the permeate, comprising the steps of:

(a) selecting an inert fluorescent tracer wherein the selection is made such that it is known in advance whether said inert fluorescent tracer is
(i) capable of traveling through the membrane into the permeate stream, or
(ii) not capable of passing through the membrane into the permeate stream;
(b) introducing the inert fluorescent tracer into the feed stream;
(c) providing one or more fluorometers to detect the fluorescent signal of the inert fluorescent tracer in at least one of the feed stream, the concentrate and optionally the permeate;
(d) using said one or more fluorometers to detect the fluorescent signal of the inert fluorescent tracer in at least one of the feed stream, the concentrate and optionally the permeate; and
(e) using the detected fluorescent signal of the inert fluorescent tracer to determine the amount of inert fluorescent tracer in at least one of the feed stream, the concentrate and optionally the permeate.

2. The method of claim 1 further comprising the step of

(f) evaluating a process parameter of the membrane separation process based on the amount of the inert fluorescent tracer that is measured.

3. The method of claim 1 wherein the membrane separation process is selected from the group consisting of a cross-flow membrane separation process and a dead-end flow membrane separation process.

4. The method of claim 3 wherein the membrane separation process is selected from the group consisting of reverse osmosis, ultrafiltration, microfiltration, nanofiltration, electrodialysis, electrodeionization, pervaporation, membrane extraction, membrane distillation, membrane stripping, membrane aeration and combinations thereof.

5. The method of claim 1 wherein the inert fluorescent tracer is selected from the group consisting of 3,6-acridinediamine, N,N,N′,N′-tetramethyl-,monohydrochloride; 2-anthracenesulfonic acid sodium salt; 1,5-anthracenedisulfonic acid; 2,6-anthracenedisulfonic acid; 1,8-anthracenedisulfonic acid; anthra[9,1,2-cde]benzo[rst]pentaphene-5,10-diol, 16,17-dimethoxy-,bis(hydrogen sulfate), disodium salt; bathophenanthrolinedisulfonic acid disodium salt; amino 2,5-benzene disulfonic acid; 2-(4-aminophenyl)-6-methylbenzothiazole; 1H-benz[de]isoquinoline-5-sulfonic acid, 6-amino-2,3-dihydro-2-(4-methylphenyl)-1,3-dioxo-, monosodium salt; phenoxazin-5-ium, 1-(aminocarbonyl)-7-(diethylamino)-3,4-dihydroxy-, chloride; benzo[a]phenoxazin-7-ium, 5,9-diamino-, acetate; 4-dibenzofuransulfonic acid; 3-dibenzofuransulfonic acid; 1-ethylquinaldinium iodide; fluorescein; fluorescein, sodium salt; Keyfluor White ST; benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[4-[bis(2-hydroxyethyl)amino]-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-,tetrasodium salt; C.I. Florescent Brightener 230; benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[4-[bis(2-hydroxyethyl)amino]-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-,tetasodium salt; 9,9′-biacridinium, 10,10′-dimethyl-, dinitrate; 1-deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10(2H)-yl)-ribitol; mono-, di-, or tri-sulfonated napthalenes selected from the group consisting of 1,5-naphthalenedisulfonic acid, disodium salt (hydrate); 2-amino-1-naphthalenesulfonic acid; 5-amino-2-naphthalenesulfonic acid; 4-amino-3-hydroxy-1-naphthalenesulfonic acid; 6-amino-4-hydroxy-2-naphthalenesulfonic acid; 7-amino-1,3-naphthalenesulfonic acid, potassium salt; 4-amino-5-hydroxy-2,7-naphthalenedisulfonic acid; 5-dimethylamino-1-naphthalenesulfonic acid; 1-amino-4-naphthalene sulfonic acid; 1-amino-7-naphthalene sulfonic acid; and 2,6-naphthalenedicarboxylic acid, dipotassium salt; 3,4,9,10-perylenetetracarboxylic acid; C.I. Fluorescent Brightener 191; C.I. Fluorescent Brightener 200; benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-(4-phenyl-2H-1,2,3-triazol-2-yl)]-, dipotassium salt; benzenesulfonic acid, 5-(2H-naphtho[1,2-d]triazol-2-yl)-2(2-phenylethenyl)-, sodium salt; 1,3,6,8-pyrenetetrasulfonic acid, tetrasodium salt; pyranine; quinoline; 3H-phenoxazin-3-one, 7-hydroxy-, 10-oxide; xanthylium, 9-(2,4-dicarboxyphenyl)-3,6-bis(diethylamino)-, chloride, disodium salt; phenazinium, 3,7-diamino-2,8-dimethyl-5-phenyl-, chloride; C.I. Fluorescent Brightener 235; benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4-[bis(2-hydroxyethyl)amino]-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-, tetrasodium salt; benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4-[(2-hydroxypropyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt; xanthylium, 3,6-bis(diethylamino)-9-(2,4-disulfophenyl)-, inner salt, sodium salt; benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[4-[(aminomethyl)(2-hydroxyethyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt; Tinopol DCS; benzenesulfonic acid, 2,2′-([1,1′-biphenyl]-4,4′-diyldi-2,1-ethenediyl)bis, disodium salt; benzenesulfonic acid, 5-(2H-naphtho[1,2-d]triazol-2-yl)-2-(2-phenylethenyl)-, sodium salt; 7-benzothiazolesulfonic acid, 2,2′-(1-triazene-1,3-diyldi-4,1-phenylene)bis[6-methyl-, disodium salt; and all ammonium, potassium and sodium salts thereof; and all mixtures thereof.

6. The method of claim 1 wherein the inert fluorescent tracer is introduced into the feed stream in an amount from about 5 ppt to about 1000 ppm.

7. The method of claim 1 wherein the inert fluorescent tracer is added directly as a single component into the feed stream.

8. A method of monitoring a membrane separation system including a membrane capable of removing solutes from a feed stream, wherein said membrane is suitable for use in an industrial water system, comprising the steps of:

(a) selecting an inert fluorescent tracer wherein the selection is made such that it is known in advance whether said inert fluorescent tracer is
(i) capable of traveling through the membrane into the permeate stream, or
(ii) not capable of passing through the membrane into the permeate stream;
(b) introducing the inert fluorescent tracer into the feed stream;
(c) contacting the membrane with the feed stream;
(d) using the membrane to remove solutes from the feed stream by separating the feed stream into a permeate stream and a concentrate stream;
(e) providing one or more fluorometers to detect the fluorescent signal of the inert fluorescent tracer in at least one of the feed stream, the concentrate and optionally the permeate;
(f) using said one or more fluorometers to detect the fluorescent signal of the inert fluorescent tracer in at least one of the feed stream, the concentrate and optionally the permeate; and
(g) using the detected fluorescent signal of the inert fluorescent tracer to determine the amount of inert fluorescent tracer in at least one of the feed stream, the concentrate and optionally the permeate.

9. The method of claim 8 further comprising the step of

(h) evaluating the removal of solutes from the feed stream based on the amount of the inert tracer that is measured.

10. The method of claim 8 wherein the industrial water system is selected from the group consisting of raw water processes, waste water processes, industrial water processes, municipal water treatment, food and beverage processes, pharmaceutical processes, electronic manufacturing, utility operations, pulp and paper processes, mining and mineral processes, transportation-related processes, textile processes, plating and metal working processes, laundry and cleaning processes, leather and tanning processes, and paint processes.

11. The method of claim 8 wherein the membrane separation process is selected from the group consisting of reverse osmosis, ultrafiltration, microfiltration, nanofiltration, electrodialysis, electrodeionization, pervaporation, membrane extraction, membrane distillation, membrane stripping, membrane aeration and combinations thereof.

12. The method of claim 8 wherein the inert fluorescent tracer is selected from the group consisting of 3,6-acridinediamine, N,N,N′,N′-tetramethyl-,monohydrochloride; 2-anthracenesulfonic acid sodium salt; 1,5-anthracenedisulfonic acid; 2,6-anthracenedisulfonic acid; 1,8-anthracenedisulfonic acid; anthra[9,1,2-cde]benzo[rst]pentaphene-5,10-diol, 16,17-dimethoxy-,bis(hydrogen sulfate), disodium salt; bathophenanthrolinedisulfonic acid disodium salt; amino 2,5-benzene disulfonic acid; 2-(4-aminophenyl)-6-methylbenzothiazole; 1H-benz[de]isoquinoline-5-sulfonic acid, 6-amino-2,3-dihydro-2-(4-methylphenyl)-1,3-dioxo-, monosodium salt; phenoxazin-5-ium, 1-(aminocarbonyl)-7-(diethylamino)-3,4-dihydroxy-, chloride; benzo[a]phenoxazin-7-ium, 5,9-diamino-,acetate; 4-dibenzofuransulfonic acid; 3-dibenzofuransulfonic acid; 1-ethylquinaldinium iodide; fluorescein; fluorescein, sodium salt; Keyfluor White ST; benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[4-[bis(2-hydroxyethyl)amino]-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-,tetrasodium salt; C.I. Florescent Brightener 230; benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[4-[bis(2-hydroxyethyl)amino]-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-,tetasodium salt; 9,9′-biacridinium, 10,10′-dimethyl-, dinitrate; 1-deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10(2H)-yl)-ribitol; mono-, di-, or tri-sulfonated napthalenes selected from the group consisting of 1,5-naphthalenedisulfonic acid, disodium salt (hydrate); 2-amino-1-naphthalenesulfonic acid; 5-amino-2-naphthalenesulfonic acid; 4-amino-3-hydroxy-1-naphthalenesulfonic acid; 6-amino-4-hydroxy-2-naphthalenesulfonic acid; 7-amino-1,3-naphthalenesulfonic acid, potassium salt; 4-amino-5-hydroxy-2,7-naphthalenedisulfonic acid; 5-dimethylamino-1-naphthalenesulfonic acid; 1-amino-4-naphthalene sulfonic acid; 1-amino-7-naphthalene sulfonic acid; and 2,6-naphthalenedicarboxylic acid, dipotassium salt; 3,4,9,10-perylenetetracarboxylic acid; C.I. Fluorescent Brightener 191; C.I. Fluorescent Brightener 200; benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-(4-phenyl-2H-1,2,3-triazol-2-yl)-, dipotassium salt; benzenesulfonic acid, 5-(2H-naphtho[1,2-d]triazol-2-yl)-2-(2-phenylethenyl)-, sodium salt; 1,3,6,8-pyrenetetrasulfonic acid, tetrasodium salt; pyranine; quinoline; 3H-phenoxazin-3-one, 7-hydroxy-, 10-oxide; xanthylium, 9-(2,4-dicarboxyphenyl)-3,6-bis(diethylamino)-, chloride, disodium salt; phenazinium, 3,7-diamino-2,8-dimethyl-5-phenyl-, chloride; C.I. Fluorescent Brightener 235; benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[4-[bis(2-hydroxyethyl)amino]-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-, tetrasodium salt; benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[4-[(2-hydroxypropyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt; xanthylium, 3,6-bis(diethylamino)-9-(2,4-disulfophenyl)-, inner salt, sodium salt; benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[4-[(aminomethyl)(2-hydroxyethyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt; Tinopol DCS; benzenesulfonic acid, 2,2′-([1,1′-biphenyl]-4,4′-diyldi-2,1-ethenediyl)bis-, disodium salt; benzenesulfonic acid, 5-(2H-naphtho[1,2-d]triazol-2-yl)-2-(2-phenylethenyl)-, sodium salt; 7-benzothiazolesulfonic acid, 2,2′-(1-triazene-1,3-diyldi-4,1-phenylene)bis[6-methyl-, disodium salt; and all ammonium, potassium and sodium salts thereof; and all mixtures thereof.

13. The method of claim 8 wherein the inert tracer is measured in an amount ranging from about 5 ppt to about 1000 ppm.

14. A membrane separation system capable of purifying an aqueous feed stream suitable for use in an industrial process comprising:

(a) a semi-permeable membrane capable of separating the aqueous feed stream containing an inert tracer into a permeate stream and a concentrate stream to remove one or more solutes from the aqueous feed stream; wherein the inert fluorescent tracer is selected such that it is known in advance whether said inert fluorescent tracer is
(i) capable of traveling through the membrane into the permeate stream, or
(ii) not capable of passing through the membrane into the permeate stream;
(b) one or more fluorometers, capable of fluorometrically measuring an amount of the inert tracer ranging from about 5 ppt to about 1000 ppm in at least one of the aqueous feed stream, the concentrate and optionally the permeate wherein the detection device is capable of producing a signal indicative of the amount of inert tracer that is detected; and
(c) a controller capable of processing the signal to monitor and/or control the purification of the aqueous feed stream.

15. The membrane separation system of claim 14 wherein the controller is capable of monitoring leaks in the semi-permeable membrane based on the detected amount of inert tracer.

16. The method of claim 14 wherein the controller is capable of controllably and responsively adjusting one or more parameters specific to membrane separation in order to enhance a performance of the membrane separation system.

17. A method of monitoring and controlling a membrane separation process including a membrane capable of removing solutes from a feed stream for use in an industrial process comprising the steps of:

(a) adding an inert tracer to the feed stream; wherein the inert fluorescent tracer is selected such that it is known in advance whether said inert fluorescent tracer is
(i) capable of traveling through the membrane into the permeate stream, or
(ii) not capable of passing through the membrane into the permeate stream;
(b) contacting the membrane with the feed stream;
(c) using the membrane to remove solutes from the feed stream by separating the feed stream into a permeate stream and a concentrate stream;
(d) providing one or more fluorometers to detect the fluorescent signal of the inert fluorescent tracer in at least one of the feed stream, the concentrate and optionally the permeate;
(e) using said one or more fluorometers to detect the fluorescent signal of the inert fluorescent tracer, ranging from about 5 ppt to about 1000 ppm, in at least one of the feed stream, the concentrate and optionally the permeate; and
(f) using the detected fluorescent signal of the inert fluorescent tracer to determine the amount of inert fluorescent tracer in at least one of the feed stream, the concentrate and optionally the permeate;
(g) evaluating one or more process parameters specific to the membrane separation process based on the detectable amount of the inert tracer.

18. The method of claim 17 wherein the inert tracer is measured in an amount ranging from about 1 ppb to about 50 ppm based on the fluorescent signal of the inert tracer that is detected.

19. The method of claim 17 further comprising the step of

(h) monitoring the membrane separation process to detect leaks in the membrane based on the amount of the inert tracer that is detected in at least one of the feed stream, the concentrate and optionally the permeate.

20. The method of claim 17 wherein said method is used to control an amount of scalants and/or foulants depositing on the membrane.

Patent History
Publication number: 20040185472
Type: Application
Filed: Dec 16, 2003
Publication Date: Sep 23, 2004
Inventors: E. H. Kelle Zeiher (Naperville, IL), Bosco P. Ho (Aurora, IL), John E. Hoots (St. Charles, IL), Binaifer S. Bedford (Naperville, IL), Martin R. Godfrey (Naperville, IL)
Application Number: 10737475
Classifications
Current U.S. Class: 435/6; Bacteria Or Actinomycetales (435/7.32)
International Classification: C12Q001/68; G01N033/554; G01N033/569;